2) inhibitor induced retinopathy in CD1 and B6C3F1 mice

WITHDRAWN: Novel cyclin-dependent kinase (CDK1/2) inhibitor induced retinopathy in CD1 and B6C3F1 mice+ Ulrich. W. Laengle*, Elias Perentes, Brigitte Greiner, Min Dong, Vicente Nogues, Maryelle Kolopp Department of Toxicology/Pathology, Novartis Pharma AG, 4002-Basel, Switzerland This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

+

Disclosure: This work was supported by Novartis Pharma AG, Basel, Switzerland. *Corresponding author. Department of Toxicology/Pathology, Novartis Pharma Switzerland. Tel.: +41 61 696 8039; fax: +41 61 696 5509. E-mail address: [email protected].